<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36222686</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>04</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2165-0497</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>6</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>21</Day></PubDate></JournalIssue><Title>Microbiology spectrum</Title><ISOAbbreviation>Microbiol Spectr</ISOAbbreviation></Journal><ArticleTitle>Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication.</ArticleTitle><Pagination><StartPage>e0282222</StartPage><MedlinePgn>e0282222</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e02822-22</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1128/spectrum.02822-22</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) is a causative agent of life-threatening neurological diseases in young children. EV-A71 is highly infectious but it remains unclear how the virus disseminates from primary entry sites-the mucosa of the respiratory tract or the intestine-to secondary replication sites-skin or brain. Here, we investigated the role of dendritic cells (DCs) in EV-A71 dissemination. DCs reside in the mucosa of the airway and gut, and migrate to lymphoid tissues upon activation and, therefore, could facilitate EV-A71 dissemination to secondary replication sites. Monocyte-derived DCs were not permissive to different genotypes of EV-A71 but, notably, coculture with EV-A71-susceptiblle RD99 cells led to very efficient infection of RD99 cells. Notably, EV-A71 transmission of DCs to RD99 was independent of viral replication as a replication inhibitor did not affect transmission. Soluble heparin blocked EV-A71 transmission by DCs to RD99 cells, in contrast to antibodies against known attachment receptor DC-SIGN. These results strongly suggest that DCs might be a first target for EV-A71 and involved in viral dissemination via heparan sulfates and heparin derivatives might be an effective treatment to attenuate dissemination. <b>IMPORTANCE</b> EV-A71 is an emerging neurotropic virus that is of emerging concern and can result in polio-like illness. The exact mechanism of how EV-A71 results in neurological symptoms are unknown. In particular, the early dissemination of the virus from primary replication sites (airway and intestine) to secondary sites (central nervous system and skin) needs to be elucidated. There is evidence pointing toward a role for dendritic cells (DC) in EV-A71 transmission. Moreover, heparan sulfate (HS) binding mutations are observed in patients with severe diseases. Therefore, we evaluated the potential role of HS on DC in transmission. We find that HS are critical for transmitting EV-A71 by DC to target cells. Our data are consistent with other clinical and <i>in vitro</i> observations highlighting the importance of HS in EV-A71-induced disease.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Helgers</LastName><ForeName>Leanne C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Bhoekhan</LastName><ForeName>Michel S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pajkrt</LastName><ForeName>Dasja</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wolthers</LastName><ForeName>Katja C</ForeName><Initials>KC</Initials><AffiliationInfo><Affiliation>Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Geijtenbeek</LastName><ForeName>Teunis B H</ForeName><Initials>TBH</Initials><Identifier Source="ORCID">0000-0002-5710-2839</Identifier><AffiliationInfo><Affiliation>Department of Experimental Immunology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Sridhar</LastName><ForeName>Adithya</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-2986-4884</Identifier><AffiliationInfo><Affiliation>Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emma Children's Hospital, Department of Pediatric Infectious Diseases, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Microbiology, OrganoVIR Labs, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Microbiol Spectr</MedlineTA><NlmUniqueID>101634614</NlmUniqueID><ISSNLinking>2165-0497</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>9005-49-6</RegistryNumber><NameOfSubstance UI="D006493">Heparin</NameOfSubstance></Chemical><Chemical><RegistryNumber>9050-30-0</RegistryNumber><NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013431">Sulfates</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003713" MajorTopicYN="N">Dendritic Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="Y">Enterovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006493" MajorTopicYN="N">Heparin</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013431" MajorTopicYN="N">Sulfates</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">dendritic cells</Keyword><Keyword MajorTopicYN="N">enterovirus</Keyword><Keyword MajorTopicYN="N">picornavirus</Keyword><Keyword MajorTopicYN="N">receptors</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>10</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>10</Month><Day>12</Day><Hour>10</Hour><Minute>7</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>12</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36222686</ArticleId><ArticleId IdType="pmc">PMC9769767</ArticleId><ArticleId IdType="doi">10.1128/spectrum.02822-22</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. 2010. Clinical features, diagnosis, and management of Enterovirus 71. Lancet Neurol 9:1097–1105. doi:10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Bitnun A, Yeh EA. 2018. Acute flaccid paralysis and enteroviral infections. Curr Infect Dis Rep 20:34. doi:10.1007/s11908-018-0641-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-018-0641-x</ArticleId><ArticleId IdType="pubmed">29959591</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. 2012. Recent advances in the molecular epidemiology and control of human Enterovirus 71 infection. Curr Opin Virol 2:199–205. doi:10.1016/j.coviro.2012.02.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.009</ArticleId><ArticleId IdType="pubmed">22482716</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong KC, Wong KT. 2015. Understanding Enterovirus 71 neuropathogenesis and its impact on other neurotropic enteroviruses. Brain Pathol 25:614–624. doi:10.1111/bpa.12279.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12279</ArticleId><ArticleId IdType="pmc">PMC8029433</ArticleId><ArticleId IdType="pubmed">26276025</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee KY. 2016. Enterovirus 71 infection and neurological complications. Korean J Pediatr 59:395–401. doi:10.3345/kjp.2016.59.10.395.</Citation><ArticleIdList><ArticleId IdType="doi">10.3345/kjp.2016.59.10.395</ArticleId><ArticleId IdType="pmc">PMC5099286</ArticleId><ArticleId IdType="pubmed">27826325</ArticleId></ArticleIdList></Reference><Reference><Citation>Muehlenbachs A, Bhatnagar J, Zaki SR. 2015. Tissue tropism, pathology and pathogenesis of enterovirus infection. J Pathol 235:217–228. doi:10.1002/path.4438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.4438</ArticleId><ArticleId IdType="pubmed">25211036</ArticleId></ArticleIdList></Reference><Reference><Citation>Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245–252. doi:10.1038/32588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/32588</ArticleId><ArticleId IdType="pubmed">9521319</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellman I, Steinman RM. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255–258. doi:10.1016/S0092-8674(01)00449-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(01)00449-4</ArticleId><ArticleId IdType="pubmed">11509172</ArticleId></ArticleIdList></Reference><Reference><Citation>Engering A, Geijtenbeek TBH, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, Lanzavecchia A, Fransen J, Figdor CG, Piguet V, van Kooyk Y. 2002. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 168:2118–2126. doi:10.4049/jimmunol.168.5.2118.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.168.5.2118</ArticleId><ArticleId IdType="pubmed">11859097</ArticleId></ArticleIdList></Reference><Reference><Citation>Sallusto F, Lanzavecchia A. 2002. The instructive role of dendritic cells on T-cell responses. Arthritis Res 4(Suppl 3):S127–S132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3240143</ArticleId><ArticleId IdType="pubmed">12110131</ArticleId></ArticleIdList></Reference><Reference><Citation>Coleman CM, Gelais CS, Wu L. 2012. Cellular and viral mechanisms of HIV-1 transmission mediated by dendritic cells. Adv Exp Med Biol 762:109–130. doi:10.1007/978-1-4614-4433-6_4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4614-4433-6_4</ArticleId><ArticleId IdType="pmc">PMC3515677</ArticleId><ArticleId IdType="pubmed">22975873</ArticleId></ArticleIdList></Reference><Reference><Citation>de Witte L, de Vries RD, van der Vlist M, Yüksel S, Litjens M, de Swart RL, Geijtenbeek TB. 2008. DC-SIGN and CD150 have distinct roles in transmission of measles virus from dendritic cells to T-Lymphocytes. PLoS Pathog 4:e1000049. doi:10.1371/journal.ppat.1000049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000049</ArticleId><ArticleId IdType="pmc">PMC2277461</ArticleId><ArticleId IdType="pubmed">18421379</ArticleId></ArticleIdList></Reference><Reference><Citation>Duangkhae P, Erdos G, Ryman KD, Watkins SC, Falo LD, Marques ETA, Barratt-Boyes SM. 2018. Interplay between keratinocytes and myeloid cells drives dengue virus spread in human skin. J Invest Dermatol 138:618–626. doi:10.1016/j.jid.2017.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jid.2017.10.018</ArticleId><ArticleId IdType="pubmed">29106931</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain P, Manuel SL, Khan ZK, Ahuja J, Quann K, Wigdahl B. 2009. DC-SIGN mediates cell-free infection and transmission of human T-cell lymphotropic virus type 1 by dendritic cells. J Virol 83:10908–10921. doi:10.1128/JVI.01054-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01054-09</ArticleId><ArticleId IdType="pmc">PMC2772783</ArticleId><ArticleId IdType="pubmed">19692463</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y-W, Wang S-W, Tung Y-Y, Chen S-H. 2009. Enterovirus 71 infection of human dendritic cells. Exp Biol Med (Maywood) 234:1166–1173. doi:10.3181/0903-RM-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0903-RM-116</ArticleId><ArticleId IdType="pubmed">19596831</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X-X, Ma L, Liu Q-W, Li C, Huang Z, Wu L, Xiong S-D, Wang J-H, Wang H-B. 2014. The molecule of DC-SIGN captures Enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virol J 11:47. doi:10.1186/1743-422X-11-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-47</ArticleId><ArticleId IdType="pmc">PMC3995660</ArticleId><ArticleId IdType="pubmed">24620896</ArticleId></ArticleIdList></Reference><Reference><Citation>Pourianfar HR, Poh CL, Fecondo J, Grollo L. 2012. In vitro evaluation of the antiviral activity of heparan sulfate mimetic compounds against Enterovirus 71. Virus Res 169:22–29. doi:10.1016/j.virusres.2012.06.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2012.06.025</ArticleId><ArticleId IdType="pubmed">22771616</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam I-C, Chan YF. 2013. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol 87:611–620. doi:10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S, Cameron C, Andino R. 2002. Ribavirin's antiviral mechanism of action: lethal mutagenesis? J Mol Med (Berl) 80:86–95. doi:10.1007/s00109-001-0308-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00109-001-0308-0</ArticleId><ArticleId IdType="pubmed">11907645</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z-H, Li C-M, Ling P, Shen F-H, Chen S-H, Liu C-C, Yu C-K, Chen S-H. 2008. Ribavirin reduces mortality in Enterovirus 71-infected mice by decreasing viral replication. J Infect Dis 197:854–857. doi:10.1086/527326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. 2009. Human P-selectin glycoprotein ligand-1 is a functional receptor for Enterovirus 71. Nat Med 15:794–797. doi:10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, Koike S. 2009. Scavenger receptor B2 is a cellular receptor for Enterovirus 71. Nat Med 15:798–801. doi:10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Ohka S, Fujii K, Koike S. 2013. Functional comparison of SCARB2 and PSGL1 as receptors for Enterovirus 71. J Virol 87:3335–3347. doi:10.1128/JVI.02070-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02070-12</ArticleId><ArticleId IdType="pmc">PMC3592140</ArticleId><ArticleId IdType="pubmed">23302872</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka ED, Sobo K, Stoppini L, Cagno V, Abdul F, Piuz I, Meylan P, Huang S, Constant S, Tapparel C. 2018. A VP1 mutation acquired during an Enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog 14:e1007190. doi:10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesman AW, Zijlstra-Willems EM, Kaptein TM, de Swart RL, Davis ME, Ludlow M, Duprex WP, Gack MU, Gringhuis SI, Geijtenbeek TBH. 2014. Measles virus suppresses RIG-I-like receptor activation in dendritic cells via DC-SIGN-mediated inhibition of PP1 phosphatases. Cell Host Microbe 16:31–42. doi:10.1016/j.chom.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2014.06.008</ArticleId><ArticleId IdType="pmc">PMC4159752</ArticleId><ArticleId IdType="pubmed">25011106</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Sanden SMG, Koen G, van Eijk H, Koekkoek SM, de Jong MD, Wolthers KC. 2016. Prediction of protection against Asian Enterovirus 71 outbreak strains by cross-neutralizing capacity of serum from Dutch donors, the Netherlands. Emerg Infect Dis 22:1562–1569. doi:10.3201/eid2209.151579.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2209.151579</ArticleId><ArticleId IdType="pmc">PMC4994357</ArticleId><ArticleId IdType="pubmed">27533024</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493–497. doi:10.1093/oxfordjournals.aje.a118408.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/oxfordjournals.aje.a118408</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>